Life Science Company News

Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states

Read more ››
By: GlobeNewswire - 21 Sep 2023

Aligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009

Read more ››
By: GlobeNewswire - 21 Sep 2023

Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board

Read more ››
By: GlobeNewswire - 21 Sep 2023

PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health

Read more ››
By: GlobeNewswire - 21 Sep 2023

Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development

Read more ››
By: GlobeNewswire - 21 Sep 2023

Major protests on Ontario Legislature’s opening: Thousands to oppose Ford’s hospital privatization

Read more ››
By: GlobeNewswire - 21 Sep 2023

HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

Read more ››
By: GlobeNewswire - 21 Sep 2023

Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit

Read more ››
By: GlobeNewswire - 21 Sep 2023

New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening Program

Read more ››
By: GlobeNewswire - 21 Sep 2023

Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023

Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Read more ››
By: GlobeNewswire - 21 Sep 2023

Jasper Therapeutics to Present New Positive Data on Briquilimab Conditioning in Patients with Fanconi Anemia at the 2023 Fanconi Anemia Research Fund Scientific Symposium

Read more ››
By: GlobeNewswire - 21 Sep 2023

CymaBay Initiates AFFIRM, a Phase 3b/4 Study Evaluating the Effect of Seladelpar on Clinical Outcomes in Patients with Cirrhosis due to Primary Biliary Cholangitis

Read more ››
By: GlobeNewswire - 21 Sep 2023

IntelGenx Provides RIZAFILM® U.S. Commercialization Update

Read more ››
By: GlobeNewswire - 21 Sep 2023

Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use

Read more ››
By: GlobeNewswire - 21 Sep 2023

Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900

Read more ››
By: GlobeNewswire - 21 Sep 2023

Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update

Read more ››
By: GlobeNewswire - 21 Sep 2023

89bio Announces U.S. FDA has Granted Breakthrough Therapy Designation for Pegozafermin in Nonalcoholic Steatohepatitis (NASH)

Read more ››
By: GlobeNewswire - 21 Sep 2023

electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate